TLR4 and melanoma: In addition, injection ofpreventive DC-based vaccines transfected with mRNA encoding polypeptideβ2m-tumor peptide-TLR4 [55] orprepared using living B16 melanoma cells as a source of TAA [56] fully protected animals against thedevelopment of B16 melanoma.